Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Schnell, Matthias
Item TypeName
Concept Virus Replication
Academic Article Characterization of a single-cycle rabies virus-based vaccine vector.
Academic Article MicroRNA-122: a therapeutic target for hepatitis C virus (HCV) infection.
Academic Article Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells.
Academic Article Both viral transcription and replication are reduced when the rabies virus nucleoprotein is not phosphorylated.
Academic Article Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design.
Academic Article Identification of viral genomic elements responsible for rabies virus neuroinvasiveness.
Academic Article In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife.
Academic Article Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice.
Academic Article siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
Academic Article The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription.
Academic Article The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread.
Academic Article Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity.
Academic Article Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.
Academic Article A novel composite immunotoxin that suppresses rabies virus production by the infected cells.
Academic Article A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19.
Search Criteria
  • Virus Replication